Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-009000

President and CEO bought 6,400 shares at $1.53 ($9,792)

  • President and CEO gave up 5,343 shares (to pay taxes)
  • President and CEO acquired 15,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-31 Exercise or conversion : show line 1 in the form +15,450 96,730 D
2022-03-31 Shares withheld for taxes : show line 2 in the form −5,343 $1.54 $8,228 91,387 D
2022-03-31 Purchase : show line 3 in the form +6,400 $1.53 $9,792 97,787 D
Open-market purchases · 6,400 sh · avg $1.53 · $9,792

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-31 Exercise or conversion : show line 4 in the form Restricted Stock Units −15,450 15,450 D
Loading xslF345X03/ownership.xml…